Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 CAD | +3.05% | +13.45% | +542.86% |
Sales 2024 * | - | Sales 2025 * | 438K 319K | Capitalization | 196M 143M |
---|---|---|---|---|---|
Net income 2024 * | -15M -10.93M | Net income 2025 * | -19M -13.84M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 448 x |
P/E ratio 2024 * |
-11.5
x | P/E ratio 2025 * |
-9.89
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.81% |
Latest transcript on Medicenna Therapeutics Corp.
1 day | -7.09% | ||
1 week | +13.42% | ||
Current month | +12.93% | ||
1 month | +54.12% | ||
3 months | +463.44% | ||
6 months | +429.29% | ||
Current year | +523.81% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 2.7 | +3.05% | 48 116 |
24-05-08 | 2.62 | -7.09% | 121,811 |
24-05-07 | 2.82 | +15.57% | 163,945 |
24-05-06 | 2.44 | +2.09% | 95,461 |
24-05-03 | 2.39 | +0.42% | 75,944 |
Delayed Quote Toronto S.E., May 08, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+523.81% | 143M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- MDNA Stock